Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging

被引：0
|
作者：
Lorena Consolino
Dario Livio Longo
Marianna Sciortino
Walter Dastrù
Sara Cabodi
Giovanni Battista Giovenzana
Silvio Aime
机构：
[1] University of Torino,Department of Molecular Biotechnology and Health Sciences
[2] CAGE Chemicals srl,Institute of Biostructure and Bioimaging
[3] National Research Council of Italy (CNR) c/o Molecular Biotechnologies Center,Department of Pharmaceutical Sciences
[4] University of Eastern Piedmont,undefined
来源：
Gastric Cancer | 2017年 / 20卷
关键词：
Gastrointestinal stromal tumor; Angiogenesis; DCE-MRI; Imatinib; Gadolinium contrast agent;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：629 / 639
页数：10
相关论文
共 50 条
  • [21] Dynamic contrast-enhanced magnetic resonance imaging in correlation with tongue cancer stages
    Chen, Chih-Feng
    Peng, Shin-Lei
    Lee, Chen-Chang
    Lui, Chun-Chung
    Huang, Hsuan-Ying
    Chien, Chih-Yen
    ACTA RADIOLOGICA, 2021, 62 (12) : 1618 - 1624
  • [22] Assessing the reproducibility of high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging in patients with gliomas
    Lim, Woo Hyeon
    Park, Joon Sik
    Park, Jaeseok
    Choi, Seung Hong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [23] Automated lesion detection in dynamic contrast-enhanced magnetic resonance imaging of breast
    Liang, Xi
    Kotagiri, Ramamohanarao
    Frazer, Helen
    Yang, Qing
    MEDICAL IMAGING 2015: COMPUTER-AIDED DIAGNOSIS, 2015, 9414
  • [24] Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging
    Gulliksrud, Kristine
    Ovrebo, Kirsti Marie
    Mathiesen, Bent
    Rofstad, Einar K.
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 (03) : 360 - 364
  • [25] Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer
    Tobias Franiel
    Bernd Hamm
    Hedvig Hricak
    European Radiology, 2011, 21 : 616 - 626
  • [26] Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer
    Franiel, Tobias
    Hamm, Bernd
    Hricak, Hedvig
    EUROPEAN RADIOLOGY, 2011, 21 (03) : 616 - 626
  • [27] Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Staging of Bladder Cancer
    Rabie, Elham
    Faeghi, Fariborz
    Izadpanahi, Mohammad-Hossein
    Dayani, Mohammad-Ali
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (04) : TC1 - TC5
  • [28] Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments
    Zhang, Yue
    Kapur, Payal
    Yuan, Qing
    Xi, Yin
    Carvo, Ingrid
    Signoretti, Sabina
    Dimitrov, Ivan
    Cadeddu, Jeffrey A.
    Margulis, Vitaly
    Muradyan, Naira
    Brugarolas, James
    Madhuranthakam, Ananth J.
    Pedrosa, Ivan
    CLINICAL GENITOURINARY CANCER, 2016, 14 (01) : E25 - E36
  • [29] Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Imaging Biomarker for Vascular Normalization Effect of Infigratinib in High-FGFR-Expressing Hepatocellular Carcinoma Xenografts
    Tran, Anh
    Koh, Tong San
    Prawira, Aldo
    Ho, Rebecca Zhi Wen
    Le, Thi Bich Uyen
    Vu, Thanh Chung
    Hartano, Septian
    Teo, Xing Qi
    Chen, Way Cherng
    Lee, Philip
    Thng, Choon Hua
    Huynh, Hung
    MOLECULAR IMAGING AND BIOLOGY, 2021, 23 (01) : 70 - 83
  • [30] Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Prostate Cancer Clinical Trials: Potential Roles and Possible Pitfalls
    Fennessy, Fiona M.
    Mckay, Rana R.
    Beard, Clair J.
    Taplin, Mary-Ellen
    Tempany, Clare M.
    TRANSLATIONAL ONCOLOGY, 2014, 7 (01): : 120 - 129
12345